急性腎臓損傷治療の世界市場

急性腎臓損傷治療の世界市場は2030年までに25億米ドルに達する

2024年に18億米ドルと推定される急性腎臓損傷治療の世界市場は、分析期間2024-2030年にCAGR 5.9%で成長し、2030年には25億米ドルに達すると予測されます。本レポートで分析されているセグメントの1つである前腎急性腎臓損傷治療は、CAGR 5.2％を記録し、分析期間終了までに14億米ドルに達すると予測されています。本質的腎急性腎臓損傷治療セグメントの成長率は、分析期間中CAGR 6.7％と推定されます。

米国市場は4億7,840万米ドル、中国はCAGR 9.2％で成長予測

米国の急性腎臓損傷治療市場は、2024年に4億7,840万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.2%で推移し、2030年には4億9,950万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0％と5.8％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の急性腎臓損傷（AKI）治療市場- 主要動向と促進要因のまとめ

急性腎不全が多臓器ケアと重症患者管理の重要な焦点になりつつあるのはなぜか？

急性腎臓損傷（AKI）-腎機能が突然低下し、多くの場合可逆的に低下すること-は、入院患者や重症患者における深刻な合併症として認識されつつあります。敗血症、脱水、薬物中毒、虚血などが引き金となることが多く、高い罹患率、死亡率、入院期間の延長を伴う。特に高齢化社会と集中治療環境におけるAKIの増加は、タイムリーな診断、支持的介入、専門的な治療戦略に対する需要を高めています。

AKIはしばしば慢性腎臓病（CKD）や多臓器不全の前駆症状となるため、早期発見と早期介入は腎機能を維持し生存率を向上させるための中心となっています。このため、AKI治療は腎臓内科、救急医療、救命救急医療における統合ケアパスの重要な構成要素となっています。

効果的なAKI管理のために、治療アプローチと腎支援技術はどのように進化しているのでしょうか？

現在の治療パラダイムは、血行動態の安定化、水分と電解質のバランス、腎毒性薬剤の中止などの支持療法に重点を置いています。腎代替療法（RRT）-間歇的血液透析、持続的腎代替療法（CRRT）、腹膜透析-は重症例や難治性症例に用いられます。特にCRRTは、より穏やかな輸液管理と血行動態の適合性から、ICUの環境において支持を集めています。

製薬研究では、虚血性障害、炎症、酸化ストレスの緩和を目的とした腎保護薬の研究が進められています。NGAL、KIM-1、シスタチンCなどのバイオマーカーによる診断がリスク層別化プロトコールに組み込まれつつあり、より早期の治療介入を可能にしています。透析装置、生体適合性膜、自動体液管理システムの革新は、AKI治療における治療精度と患者の安全性をさらに高めています。

AKI治療の需要を牽引している患者グループとヘルスケア環境は？

AKIは、高齢者、ICU患者、敗血症患者、大手術中や造影剤投与中の患者に頻繁に発症します。また、腫瘍学、心臓病学、移植医療においても、腎毒性レジメンへの曝露が原因となって多く見られます。病院や集中治療室が主な治療環境であり、フォローアップや腎機能モニタリングのために腎臓内科クリニックや急性期リハビリテーションセンターがそれに続きます。

北米と欧州は、高度な病院インフラ、高い認知度、包括的なクリティカルケア体制に支えられ、大きな市場シェアを占めています。アジア太平洋地域では、人口動態の変化、ICUの収容能力の増加、抗生物質の過剰使用や感染症負担などの危険因子への曝露の増加により、発生率が増加しています。新興国は、臨床医の研修や機器の調達を通じて、AKI対策への投資を徐々に進めています。

政策イニシアティブ、技術統合、リスク管理は市場拡大をどのように形成しているか？

医療当局は、臨床ガイドライン、リスク評価プロトコル、病院ベースの警告システムを通じて、AKIの予防と早期介入を優先しています。KDIGOのような団体による標準化の取り組みは、輸液管理、薬物モニタリング、腎補助療法におけるベストプラクティスを推進しています。一方、EHRに統合されたAKIアラートシステムは、リアルタイムの検出と臨床的な意思決定に役立っています。

バリューベースドケアモデルとバンドルペイメントシステムは、早期AKIスクリーニングと透析導入回避への投資を促進しています。病院では腎機能サーベイランスのためのデジタルツールの導入が進んでおり、研究開発機関ではバイオマーカー開発や新薬候補の開発を加速させるために産業界との協力が進んでいます。このような分野横断的な取り組みにより、AKIの臨床的な認知度が高まり、腎ケア提供の体系的な改善が促進されつつあります。

AKI治療市場の成長を促す要因は何か？

AKI治療市場は、高リスク集団における発症率の上昇、クリティカルケア能力の拡大、腎サポート技術の採用増加を受けて成長しています。主な促進要因としては、臨床的緊急性、治療ガイドラインの進化、CRRTプラットフォームの革新、急性期医療のワークフローへの診断の統合の深化などが挙げられます。医療システムがさまざまな疾患において腎機能温存を優先する中、AKI治療は病院での治療の中核となりつつあります。

今後、市場の勢いは、利害関係者がいかに効果的に早期発見を拡大し、介入を調整し、慢性腎臓合併症への進展を抑制できるかにかかっています。腎臓の健康が多臓器疾患の管理の中心になるにつれて、急性腎臓損傷治療は集中治療や予防的治療のパスウェイ全体の転帰を変える戦略的なテコとして台頭してくる可能性があります。

セグメント

タイプ（腎前性、本態性、腎後性）、治療（治療法、薬剤）、流通チャネル（病院薬局、小売薬局、オンライン薬局）

調査対象企業の例（注目の36社）

• AbbVie Inc.
• Amanta Healthcare
• Amgen Inc.
• AM-Pharma B.V.
• Angion Biomedica Corp.
• Arch Biopartners Inc.
• Asahi Kasei Medical Co., Ltd.
• AstraZeneca plc
• B. Braun Melsungen AG
• Baxter International Inc.
• Bristol-Myers Squibb Company
• CalciMedica, Inc.
• Eli Lilly and Company
• Fresenius Medical Care AG & Co. KGaA
• GE Healthcare
• Gilead Sciences, Inc.
• Guard Therapeutics AB
• ICU Medical, Inc.
• Kringle Pharma, Inc.
• LG Chem Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Acute Kidney Injury Treatment Market to Reach US$2.5 Billion by 2030

The global market for Acute Kidney Injury Treatment estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Prerenal Acute Kidney Injury Treatment, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Intrinsic Renal Acute Kidney Injury Treatment segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$478.4 Million While China is Forecast to Grow at 9.2% CAGR

The Acute Kidney Injury Treatment market in the U.S. is estimated at US$478.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$499.5 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Acute Kidney Injury (AKI) Treatment Market - Key Trends & Drivers Summarized

Why Is Acute Kidney Injury Emerging as a Critical Focus in Multisystem Care and Critical Illness Management?

Acute Kidney Injury (AKI)-a sudden and often reversible decline in renal function-is increasingly recognized as a serious complication in hospitalized and critically ill patients. Commonly triggered by sepsis, dehydration, drug toxicity, or ischemia, AKI is associated with high morbidity, mortality, and extended hospital stays. Its growing prevalence, particularly in aging populations and intensive care settings, is driving demand for timely diagnosis, supportive interventions, and specialized treatment strategies.

With AKI often serving as a precursor to chronic kidney disease (CKD) or multi-organ failure, early recognition and intervention have become central to preserving renal function and improving survival rates. This has made AKI treatment an essential component of integrated care pathways in nephrology, emergency medicine, and critical care.

How Are Therapeutic Approaches and Renal Support Technologies Evolving for Effective AKI Management?

Current treatment paradigms focus on supportive care, including hemodynamic stabilization, fluid and electrolyte balance, and withdrawal of nephrotoxic agents. Renal replacement therapy (RRT)-through intermittent hemodialysis, continuous renal replacement therapy (CRRT), or peritoneal dialysis-is used in severe or refractory cases. CRRT, in particular, is gaining traction in ICU settings due to its gentler fluid management and hemodynamic compatibility.

Pharmaceutical research is exploring renoprotective agents aimed at mitigating ischemic damage, inflammation, and oxidative stress. Biomarker-driven diagnostics-such as NGAL, KIM-1, and cystatin C-are being incorporated into risk stratification protocols, enabling earlier therapeutic intervention. Innovations in dialysis machines, biocompatible membranes, and automated fluid management systems are further enhancing treatment precision and patient safety in AKI care.

Which Patient Groups and Healthcare Settings Are Driving AKI Treatment Demand?

AKI frequently affects elderly individuals, ICU patients, individuals with sepsis, and those undergoing major surgery or receiving contrast agents. It is also prevalent in oncology, cardiology, and transplant care due to exposure to nephrotoxic regimens. Hospitals and intensive care units are the primary treatment environments, followed by nephrology clinics and post-acute rehabilitation centers for follow-up and renal function monitoring.

North America and Europe account for significant market share, supported by advanced hospital infrastructure, high awareness, and comprehensive critical care frameworks. Asia-Pacific is witnessing increasing incidence due to demographic transitions, growing ICU capacity, and rising exposure to risk factors such as antibiotic overuse and infectious disease burden. Emerging economies are gradually investing in AKI preparedness through clinician training and equipment procurement.

How Are Policy Initiatives, Technological Integration, and Risk Management Practices Shaping Market Expansion?

Health authorities are prioritizing AKI prevention and early intervention through clinical guidelines, risk assessment protocols, and hospital-based alert systems. Standardization efforts from bodies such as KDIGO (Kidney Disease: Improving Global Outcomes) are promoting best practices in fluid management, drug monitoring, and renal support therapy. Meanwhile, EHR-integrated AKI alert systems are aiding real-time detection and clinical decision-making.

Value-based care models and bundled payment systems are driving investments in early AKI screening and avoidance of dialysis initiation. Hospitals are increasingly adopting digital tools for kidney function surveillance, while research institutions are collaborating with industry to accelerate biomarker development and novel drug candidates. These cross-sector efforts are raising the clinical profile of AKI and catalyzing systemic improvements in renal care delivery.

What Are the Factors Driving Growth in the AKI Treatment Market?

The AKI treatment market is growing in response to rising incidence in high-risk populations, expanding critical care capacity, and increasing adoption of renal support technologies. Key drivers include clinical urgency, evolving treatment guidelines, innovation in CRRT platforms, and deeper integration of diagnostics into acute care workflows. As health systems prioritize kidney function preservation across a range of conditions, AKI treatment is becoming a core focus of hospital-based care.

Looking ahead, market momentum will depend on how effectively stakeholders can scale early detection, tailor interventions, and reduce progression to chronic kidney complications. As kidney health becomes central to managing multisystem diseases, could acute kidney injury treatment emerge as a strategic lever in transforming outcomes across intensive and preventive care pathways?

SCOPE OF STUDY:

The report analyzes the Acute Kidney Injury Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury); Treatment (Therapy, Drugs); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• AbbVie Inc.
• Amanta Healthcare
• Amgen Inc.
• AM-Pharma B.V.
• Angion Biomedica Corp.
• Arch Biopartners Inc.
• Asahi Kasei Medical Co., Ltd.
• AstraZeneca plc
• B. Braun Melsungen AG
• Baxter International Inc.
• Bristol-Myers Squibb Company
• CalciMedica, Inc.
• Eli Lilly and Company
• Fresenius Medical Care AG & Co. KGaA
• GE Healthcare
• Gilead Sciences, Inc.
• Guard Therapeutics AB
• ICU Medical, Inc.
• Kringle Pharma, Inc.
• LG Chem Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Acute Kidney Injury Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Hospitalization Rates for Critical Illnesses Throw the Spotlight on Acute Kidney Injury (AKI) Treatment Needs
  • Increasing Incidence of Sepsis and Cardiovascular Complications Spurs AKI Diagnosis and Intervention Demand
  • Advancements in Renal Biomarkers Strengthen the Business Case for Early AKI Detection and Treatment
  • Growing Use of Continuous Renal Replacement Therapy (CRRT) Drives Equipment and Consumable Adoption
  • Integration of AI-Based Predictive Tools in ICU Settings Bodes Well for Early AKI Risk Assessment
  • Rising Availability of Portable Dialysis Machines Expands Access to AKI Management in Non-Traditional Settings
  • Higher Adoption of EHR and Data Analytics Enhances AKI Monitoring and Decision-Making in Critical Care
  • Growth in Pediatric and Geriatric AKI Cases Sets the Stage for Demographic-Specific Treatment Protocols
  • Emergence of Biocompatible Dialysis Filters Enhances Patient Safety and Therapy Tolerance in AKI Treatment
  • Rising Focus on Post-AKI Recovery and Long-Term Kidney Function Preservation Drives Innovation in Follow-Up Care
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Acute Kidney Injury Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Acute Kidney Injury Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Prerenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Prerenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Prerenal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Intrinsic Renal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Intrinsic Renal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Intrinsic Renal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Postrenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Postrenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Postrenal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• JAPAN
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• CHINA
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• EUROPE
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Acute Kidney Injury Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• FRANCE
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• GERMANY
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• INDIA
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Acute Kidney Injury Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Acute Kidney Injury Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
• AFRICA
  • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030

IV. COMPETITION